1 / 37

HEART-LUNG TRANSPLANTATION

HEART-LUNG TRANSPLANTATION. Overall. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR. AVERAGE CENTER VOLUME Heart-Lung Transplants: January 1, 1998 - June 30, 2002. HEART-LUNG TRANSPLANTATION ACTUARIAL SURVIVAL (Transplants: January 1982 - June 2001). Half-life = 2.7 years

jewel
Download Presentation

HEART-LUNG TRANSPLANTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEART-LUNG TRANSPLANTATION Overall

  2. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR

  3. AVERAGE CENTER VOLUMEHeart-LungTransplants: January 1, 1998 - June 30,2002

  4. HEART-LUNG TRANSPLANTATIONACTUARIAL SURVIVAL (Transplants: January 1982 - June 2001) Half-life = 2.7 years Conditional Half-life = 8.1 years N=2,889 Survival (%)

  5. HEART-LUNG TRANSPLANTATION Adult Recipients

  6. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (1/1982-6/2002) “Other” includes cancer, LAM, OB, sarcoidosis, bronchiectasis

  7. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS(Transplants: January 1982 - June 2002)

  8. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS BY ERA 1982-1990 1991-1995 1/1996-6/2002 “Other” includes OB (non-ReTX), Bronchiectasis, Sarcoidosis

  9. ADULT HEART-LUNG TRANSPLANTATIONActuarial Survival By Diagnosis(Transplants: January 1990 – June 2001)

  10. ADULT HEART-LUNG TRANSPLANTATIONActuarial Survival By Diagnosis(Transplants: January 1990 – June 2001)

  11. ADULT HEART-LUNG RECIPIENTSFunctional Status (Follow-ups: April 1994 – June 2002)

  12. ADULT HEART-LUNG RECIPIENTSEmployment Status(Follow-ups: April 1994 – June 2002)

  13. ADULT HEART-LUNG RECIPIENTS: Rehospitalization Post-transplant(Follow-ups: April 1994 - June 2002)

  14. ADULT HEART-LUNG RECIPIENTS Induction ImmunosuppressionFor follow-ups between January 2000 through June 2002

  15. ADULT HEART-LUNG RECIPIENTSInduction Immunosuppression (Follow-ups: January 2000 - June 2002)

  16. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Any Time During Follow-upFor follow-ups between January 2000 through June 2002 NOTE: Different patients are analyzed in Year 1 and Year 5

  17. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between January 2000 through June 2002 NOTE: Different patients are analyzed in Year 1 and Year 5

  18. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression Drug Combinations at Time of Follow-upFor follow-ups between January 2000 through June 2002 NOTE: Different patients are analyzed in Year 1 and Year 5

  19. POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Prevalence in Survivors within 1 Year Post-Transplant(Follow-ups: April 1994-June 2002)

  20. POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Prevalence in Survivors within 5 Years Post-Transplant(Follow-ups: April 1994-June 2002)

  21. Freedom from CAV For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2002)

  22. Freedom from Bronchiolitis Obliterans For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2002)

  23. Freedom from Severe Renal Dysfunction*For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2002) *Severe renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant

  24. MALIGNANCY POST-HEART-LUNG TRANSPLANT FOR ADULTSCumulative Prevalence in Survivors(Follow-ups: April 1994-June 2002)

  25. Freedom from MalignancyFor Adult Heart-Lung Recipients(Follow-ups: April 1994- June 2002)

  26. ADULT HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(Deaths: January 1992 - June 2002)

  27. HEART-LUNG TRANSPLANTATION Pediatric Recipients

  28. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNGRECIPIENTS (Transplants: January 1982 - June 2002)

  29. AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART-LUNG RECIPIENTS(Transplants: January 1982 - June 2002)

  30. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTSBy Year of Transplant Number of Transplants

  31. NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTS

  32. “Other” includes Alpha-1, Bronchiectasis, IPF and OB (non-ReTX) DIAGNOSIS IN PEDIATRIC HEART –LUNG TRANSPLANT RECIPIENTS (Age: 11-17 Years)

  33. PEDIATRIC HEART-LUNG TRANSPLANTATIONActuarial Survival By Diagnosis(Transplants: January 1990 – June 2001)

  34. PEDIATRIC HEART-LUNG TRANSPLANTATIONActuarial Survival By Diagnosis(Transplants: January 1990 – June 2001)

  35. PEDIATRIC HEART-LUNG TRANSPLANTATIONActuarial Survival(Transplants: January 1982 - June 2002) 1-10 years vs. 11-17 years p = 0.9

  36. PEDIATRIC HEART-LUNG TRANSPLANTATION Actuarial Survival by Era(Transplants: January 1982 - June 2001) Survival (%)

  37. PEDIATRIC HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(Deaths: January 1992 - June 2002)

More Related